A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
18 08 2020
Historique:
pubmed: 5 8 2020
medline: 7 10 2020
entrez: 5 8 2020
Statut: ppublish

Résumé

Arboviruses maintain high mutation rates due to lack of proofreading ability of their viral polymerases, in some cases facilitating adaptive evolution and emergence. Here we show that, just before its 2013 spread to the Americas, Zika virus (ZIKV) underwent an envelope protein V473M substitution (E-V473M) that increased neurovirulence, maternal-to-fetal transmission, and viremia to facilitate urban transmission. A preepidemic Asian ZIKV strain (FSS13025 isolated in Cambodia in 2010) engineered with the V473M substitution significantly increased neurovirulence in neonatal mice and produced higher viral loads in the placenta and fetal heads in pregnant mice. Conversely, an epidemic ZIKV strain (PRVABC59 isolated in Puerto Rico in 2015) engineered with the inverse M473V substitution reversed the pathogenic phenotypes. Although E-V473M did not affect oral infection of

Identifiants

pubmed: 32747564
pii: 2005722117
doi: 10.1073/pnas.2005722117
pmc: PMC7443865
doi:

Substances chimiques

Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190-20197

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI134907
Pays : United States
Organisme : NIAID NIH HHS
ID : R43 AI145617
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001439
Pays : United States
Organisme : ACL HHS
ID : U01CK000512
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121452
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142759
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI120942
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Cell Host Microbe. 2019 Nov 13;26(5):606-622.e8
pubmed: 31631053
mBio. 2019 Oct 29;10(5):
pubmed: 31662457
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
Cell Host Microbe. 2018 Nov 14;24(5):731-742.e6
pubmed: 30439342
N Engl J Med. 2016 Jul 21;375(3):294-5
pubmed: 27355409
Nat Rev Microbiol. 2008 Sep;6(9):699-708
pubmed: 18587411
Rev Inst Med Trop Sao Paulo. 2017 Apr 13;59:e21
pubmed: 28423096
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Clin Microbiol Rev. 2016 Jul;29(3):487-524
pubmed: 27029595
Cell Host Microbe. 2016 Jun 8;19(6):891-900
pubmed: 27198478
Cell. 2017 Jul 13;170(2):273-283.e12
pubmed: 28708997
Science. 2017 Apr 14;356(6334):175-180
pubmed: 28360135
mBio. 2017 Jan 10;8(1):
pubmed: 28074023
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Nat Med. 2017 Jun;23(6):763-767
pubmed: 28394328
Nat Commun. 2018 Jan 29;9(1):414
pubmed: 29379028
mBio. 2016 Oct 11;7(5):
pubmed: 27729507
J Infect Dis. 2019 Jul 31;220(5):735-742
pubmed: 31053842
Nature. 2016 Apr 19;533(7603):425-8
pubmed: 27093288
EBioMedicine. 2019 Jun;44:516-529
pubmed: 31130472
Am J Trop Med Hyg. 2016 Jun 1;94(6):1362-1369
pubmed: 27022155
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Cell Rep. 2017 Oct 31;21(5):1180-1190
pubmed: 29091758
Antiviral Res. 2010 Feb;85(2):328-45
pubmed: 19857523
Nature. 2017 May 25;545(7655):482-486
pubmed: 28514450
Science. 2017 Nov 17;358(6365):933-936
pubmed: 28971967
Science. 2016 Apr 22;352(6284):467-70
pubmed: 27033547
Nat Commun. 2018 Feb 2;9(1):475
pubmed: 29396410
Emerg Microbes Infect. 2019;8(1):242-244
pubmed: 30866777
N Engl J Med. 2016 May 19;374(20):1981-7
pubmed: 27074377
EBioMedicine. 2017 Mar;17:145-156
pubmed: 28196656
Immunity. 2019 Mar 19;50(3):751-762.e5
pubmed: 30737148
PLoS Negl Trop Dis. 2019 Apr 17;13(4):e0007343
pubmed: 30995223
Cell Host Microbe. 2018 Nov 14;24(5):743-750.e5
pubmed: 30439343
ACS Infect Dis. 2018 May 11;4(5):656-659
pubmed: 29355007

Auteurs

Chao Shan (C)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071 Wuhan, China.

Hongjie Xia (H)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.

Sherry L Haller (SL)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Translational Science, University of Texas Medical Branch, Galveston, TX 77555.

Sasha R Azar (SR)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Translational Science, University of Texas Medical Branch, Galveston, TX 77555.

Yang Liu (Y)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.

Jianying Liu (J)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.

Antonio E Muruato (AE)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.

Rubing Chen (R)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Translational Science, University of Texas Medical Branch, Galveston, TX 77555.
Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555.

Shannan L Rossi (SL)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555.

Maki Wakamiya (M)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.

Nikos Vasilakis (N)

Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555.
World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX 77555.
Center for Biodefence and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555.
Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX 77555.

Rongjuan Pei (R)

State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071 Wuhan, China.

Camila R Fontes-Garfias (CR)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.

Sanjay Kumar Singh (SK)

Department of Neurosurgery-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

Xuping Xie (X)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.

Scott C Weaver (SC)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Translational Science, University of Texas Medical Branch, Galveston, TX 77555.
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555.
Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555.

Pei-Yong Shi (PY)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.
Institute for Translational Science, University of Texas Medical Branch, Galveston, TX 77555.
Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555.
Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH